SEC Form 4 · accession 0001179110-18-002258
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jessica Hopfield
Director
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $34.59 | Feb 14, 2018 | A | 23,076 | A | — | Feb 13, 2028 | Common Stock | 23,076 | 23,076 | D |
Explanation of responses
- F1This option was granted on February 14, 2018 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on February 14, 2019 through February 14, 2021.